Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | STRO | ABOS | ||
| Company | Cellectis S.A. ADR | Sutro Biopharma Inc | Acumen Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.81 | 25.42 | 3.37 | ||
| High | 3.83 | 25.99 | 3.46 | ||
| Low | 3.73 | 24.54 | 3.18 | ||
| Latest | 3.80 | 24.54 | 3.37 | ||
| Change | -0.02 | -0.89 | +0.01 | ||
| % Change | -0.52% | -3.50% | +0.30% | ||
| Volume | 30,400 | 48,700 | 275,800 | ||
| 20-Day Average Volume | 41,475 | 139,480 | 307,490 | ||
| Previous Close | 3.82 | 25.43 | 3.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.82 | 20.16 | 2.92 | ||
| 20-Day Raw Stochastic | 42.35% | 82.24% | 89.28% | ||
| 20-Day Relative Strength | 47.60 | 71.67 | 67.47 | ||
| Weighted Alpha | +118.86 | +215.77 | +166.38 | ||
| Today's Opinion | 8% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | Hold | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.33% since 03/04/26 | +15.16% since 03/04/26 | +1.81% since 03/04/26 | ||
| Low | 3.52 on 03/09/26 | 20.73 on 03/05/26 | 3.05 on 03/09/26 | ||
| High | 3.95 on 03/10/26 | 26.54 on 03/09/26 | 3.49 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | +4.11% since 02/11/26 | +56.01% since 02/11/26 | +31.64% since 02/11/26 | ||
| Low | 3.44 on 02/12/26 | 15.41 on 02/13/26 | 2.34 on 02/12/26 | ||
| High | 4.29 on 02/25/26 | 26.54 on 03/09/26 | 3.49 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | -27.20% since 12/11/25 | +150.15% since 12/11/25 | +71.94% since 12/11/25 | ||
| Low | 3.43 on 02/05/26 | 8.48 on 12/19/25 | 1.67 on 01/12/26 | ||
| High | 5.10 on 12/29/25 | 26.54 on 03/09/26 | 3.49 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +27.52% since 09/11/25 | +152.99% since 09/11/25 | +142.45% since 09/11/25 | ||
| Low | 2.48 on 09/29/25 | 7.15 on 12/03/25 | 1.21 on 09/16/25 | ||
| High | 5.48 on 10/16/25 | 26.54 on 03/09/26 | 3.49 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 212,316 | 216,498 | 203,525 | ||
| Shares Outstanding, K | 55,580 | 8,514 | 60,573 | ||
| Annual Sales | 49,220,000 | 62,040,000 | 0 | ||
| Annual Net Income | -36,760,000 | -227,460,000 | -102,330,000 | ||
| Last Quarter Sales | 37,160,000 | 9,690,000 | 0 | ||
| Last Quarter Net Income | 590,000 | -56,860,000 | -26,450,000 | ||
| 60-Month Beta | 2.85 | 1.47 | 0.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 11/07/25 | -6.70 on 11/06/25 | -0.44 on 11/12/25 | ||
| Latest Earnings Date | 03/12/26 | 03/12/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||